Clinical trial

Portfolio 5 - Multicentre Dietary Advice on Serum Lipids in Hyperlipidemia

NCT00438425 · University of Toronto, Other · Completed

Key facts

NCT number NCT00438425
Title Portfolio 5 - Multicentre Dietary Advice on Serum Lipids in Hyperlipidemia
Official title Assessment of the Practical Application, Acceptability and Effectiveness of a Portfolio Diet in Reducing Serum Cholesterol
Lead sponsor University of Toronto, Other
Collaborators Canadian Institutes of Health Research (CIHR) Loblaw Companies Limited Industry Solae, LLC Unilever R&D
Status Completed
Study type Interventional
Conditions Hyperlipidemia, Cardiovascular Disease
Intervention type Dietary Supplement
Interventions Dietary Portfolio - Intensive, Dietary Portfolio - Routine, Control (low saturated fat therapeutic diet)
Enrollment 351
Start date Jun 25, 2007
Primary completion Sep 30, 2009
Completion Mar 31, 2010
First posted Feb 22, 2007
Last update posted Oct 15, 2018
Countries Canada

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies